HIMSS21
PharmStars CEO Naomi Fried discusses how her company, through its PharmaU program, prepares digital health startups and pharma executives for successful partnerships.
HIMSS21
There needs to be a bidirectional flow of social determinants of health data about a patient between healthcare systems and community organizations, says ProMedica's Sandy Lewallen.
HIMSS21
Clinical trials need to treat participants as people, not just data subjects, says Pluto Health CEO Dr. Joy Bhosai.
HIMSS21
Using artificial intelligence to check medication histories helped limit face-to-face contact during the COVID-19 pandemic, explains Rebecca Sulfridge, clinical pharmacy specialist, emergency medicine, at Covenant HealthCare.
HIMSS21
Juli.co CEO Bettina Hein discusses how the juli app uses AI to help providers and patients manage complex conditions such as asthma, depression, bipolar disorder, migraine and chronic pain using formerly siloed data.
HIMSS21
Patientory collects data not found in an EHR and uses it to create a personalized health plan, says founder and CEO Chrissa McFarlane.
HIMSS21 Digital
We have to ask patients what they want and give them treatments and tools that align with what they are looking for, says Jen Horonjeff, founder and CEO of Savvy Cooperative.
HIMSS21
AdaRose CEO Lygeia Ricciardi says women typically take on a chief health officer type role in their families, so her company gives them the resources to take advantage of digital health tools to make that role easier.
HIMSS21
Virtual assistants are the future for both patients and providers, explains Dr. Yaa Kumah-Crystal, assistant professor of biomedical informatics at Vanderbilt University Medical Center.
Mary Langowski, CEO of Solera Health, says payers want to know how to change the experience to make access easy for beneficiaries.
